Esonix(Esomeprazole)

Therapeutic Group: Gastro Intestinal Disorders Presentation Esonix 20 tablet: Each delayed release tablet contains Esomeprazole Magnesium Trihydrate BP equivalent to Esomeprazole 20 mg. Esonix 40 tablet: Each delayed release tablet contains Esomeprazole Magnesium Trihydrate BP equivalent to Esomeprazole 40 mg. Esonix 20 capsule: Each delayed release capsule contains Esomeprazole Magnesium Trihydrate BP equivalent to Esomeprazole […]

Esipram(Escitalopram)

Therapeutic Group: Drugs of Nervous System Presentation Esipram 5: Each tablet contains Escitalopram INN 5 mg (as Escitalopram Oxalate). Esipram 10: Each tablet contains Escitalopram INN 10 mg (as Escitalopram Oxalate). Description The antidepressant action of escitalopram is presumably linked to the potentiation of serotonergic activity in the central nervous system (CNS) resulting from its […]

Epoetin(Erythropoietin)

Therapeutic Group: Drugs for Hematological Disorder Presentation Epoetin 2000 IU: Each prefilled syringe contains 0.5 ml sterile isotonic solution which contains recombinant Erythropoietin concentrated solution BP equivalent to Erythropoietin 2000 IU. Epoetin 3000 IU: Each prefilled syringe contains 0.75 ml sterile isotonic solution which contains recombinant Erythropoietin concentrated solution BP equivalent to Erythropoietin 3000 IU. […]

FIRMAC PLUS(Erythromycin+Sulphadiazine + Trimethoprim)

Therapeutic Group: Anti Bacterial Presentation Firmac Plus: Each gram powder contains Erythromycin Thiocyanate INN 180 mg, Sulfadiazine BP 150 mg and Trimethoprim BP 30 mg. Description The ingredients of Erythromycin, Sulphadiazine and Trimethoprim are antifolate drug that inhibits bacterial protein synthesis, antifolate drugs and able to kill bacteria. The combination has synergistic activity against wide […]

Firmac(Erythromycin)

Therapeutic Group: Anti Bacterial Presentation Firmac 250: Each tablet contains Erythromycin Stearate BP equivalent to Erythromycin 250 mg. Firmac : Each tablet contains Erythromycin Stearate BP equivalent to Erythromycin 500 mg. Firmac Dry Suspension: After reconstitution, each 5 ml suspension contains Erythromycin Ethylsuccinate BP equivalent to Erythromycin 125 mg. Description Erythromycin is highly effective against […]

ElteroTM(Ertugliflozin)

Therapeutic Group: Anti Diabetic Presentation Eltero 5: Each film-coated tablet contains Ertugliflozin L Pyroglutamic Acid INN, equivalent to Ertugliflozin 5 mg. Eltero 15: Each film-coated tablet contains Ertugliflozin L Pyroglutamic Acid INN, equivalent to Ertugliflozin 15 mg. Description SGLT2 is the predominant transporter responsible for the reabsorption of glucose from the glomerular filtrate back into […]

Wandara(Ertapenem for Injection)

Therapeutic Group: Antibiotic Presentation Wandara TM : Each vial contains sterile lyophilized powder of Ertapenem for Injection INN equivalent to Ertapenem 1 gm. Description Ertapenem for Injection is a sterile, synthetic, long-acting, parenteral, 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics, such as penicillins and cephalosporins, with activity against a wide range of Gram-positive […]

Erlocent(Erlotinib)

Therapeutic Group: Oncology Presentation Erlocent 100: Each tablet contains Erlotinib Hydrochloride INN equivalent to Erlotinib 100 mg. Erlocent 150: Each tablet contains Erlotinib Hydrochloride INN equivalent to Erlotinib 150 mg. Description Erlotinib, a kinase inhibitor, is a quinazolinamine with the chemical name N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)4-quinazolinamine. Erlotinib reversibly inhibits the kinase activity of EGFR, preventing autophosphorylation of tyrosine […]

Spusoft(Erdosteine 300 mg)

Therapeutic Group: Mucolytic drug Presentation Spusoft Capsule: Each capsule contains Erdosteine INN 300 mg Description Erdosteine is a mucolytic drug. It is a prodrug and it becomes active after metabolism. It acts by reducing the viscosity of mucus. In addition, it has asignificant antioxidant action and it inhibits bacterial adhesion to epithelial cells. Indications Erdosteine […]

Integril(Eptifibatide )

Therapeutic Group: Cardiovascular Presentation Integril 2 Injection: Each ml of sterile solution contains Eptifibatide INN 2 mg. Integril 0.75 Injection: Each ml of sterile solution contains Eptifibatide INN 0.75 mg. Description Eptifibatide is a cyclic heptapeptide containing six amino acids and one mercaptopropionyl (des-amino cysteinyl) residue. Integril binds to the platelet receptor glycoprotein (GP) IIb/IIIa […]